Author(s): Asim Ahmed Elnour, Abdulla Shehab, Akshaya Sirknath, Naama MS Al Kalbani, Ahmed Ataia, and Sahar Asim
The World Health Organization (WHO) defines pharmacovigilance as “the science and activities relating to the detection, assessment, understanding and prevention of adverse affects or any other possible drug-related problems.”
The safety monitoring of pharmaceuticals is a fundamental component of daily clinical practice. Providing high eminence medical care, ongoing safety monitoring and evaluation of effectiveness are essential to the perpetual use of pharmaceuticals. Pharmacovigilance is recognized as a clinical discipline and it serves as an indicator of the standards of clinical care practiced within a country.